These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15929953)

  • 1. Exacerbations in {alpha}1-antitrypsin deficiency.
    Needham M; Stockley RA
    Eur Respir J; 2005 Jun; 25(6):992-1000. PubMed ID: 15929953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ).
    Dowson LJ; Guest PJ; Stockley RA
    Chest; 2002 Oct; 122(4):1247-55. PubMed ID: 12377849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Transplantation in Alpha-1-Antitrypsin Deficiency.
    Stone HM; Edgar RG; Thompson RD; Stockley RA
    COPD; 2016; 13(2):146-52. PubMed ID: 26488418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline.
    Dowson LJ; Guest PJ; Stockley RA
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1805-9. PubMed ID: 11734427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in alpha1-antitrypsin deficiency.
    Dawkins PA; Dowson LJ; Guest PJ; Stockley RA
    Thorax; 2003 Dec; 58(12):1020-6. PubMed ID: 14645964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy.
    Campos MA; Alazemi S; Zhang G; Wanner A; Salathe M; Baier H; Sandhaus RA
    Respir Med; 2009 Oct; 103(10):1532-9. PubMed ID: 19464158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.
    Parr DG; Guest PG; Reynolds JH; Dowson LJ; Stockley RA
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1215-21. PubMed ID: 17872489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe exacerbations predict excess lung function decline in asthma.
    Bai TR; Vonk JM; Postma DS; Boezen HM
    Eur Respir J; 2007 Sep; 30(3):452-6. PubMed ID: 17537763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Exacerbations in Alpha-1 Antitrypsin Deficiency Using Clinical and Pulmonary Function Tests: Portuguese EARCO Registry.
    Faria N; Gomes J; Guimarães C; Marçôa R; Ferraz B; Sucena M
    Respiration; 2024; 103(6):317-325. PubMed ID: 38531325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
    Barros-Tizón JC; Torres ML; Blanco I; Martínez MT;
    Ther Adv Respir Dis; 2012 Apr; 6(2):67-78. PubMed ID: 22354900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life in Patients With α1 Antitrypsin Deficency: A Cross Sectional Study.
    Torres Redondo M; Campoa E; Ruano L; Sucena M
    Arch Bronconeumol; 2017 Feb; 53(2):49-54. PubMed ID: 27470706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.
    Gauvain C; Mornex JF; Pison C; Cuvelier A; Balduyck M; Pujazon MC; Fournier M; AitIlalne B; Thabut G
    COPD; 2015 May; 12 Suppl 1():46-51. PubMed ID: 25938292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency.
    Dowson LJ; Newall C; Guest PJ; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 2001 Mar; 163(4):936-41. PubMed ID: 11282769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.
    Machado RF; Stoller JK; Laskowski D; Zheng S; Lupica JA; Dweik RA; Erzurum SC
    J Appl Physiol (1985); 2002 Dec; 93(6):2038-43. PubMed ID: 12391056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha 1-antitrypsin deficiency: the Brescia clinical study].
    Pini L; Corda L; Malerba M; Montanelli A; Favagrossa GM; Terzi A; Marcobruni N; Magoni M; Franchini D; Radaeli A; Tantucci C; Grassi V
    Recenti Prog Med; 2000; 91(7-8):352-61. PubMed ID: 10932919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous alpha 1-antitrypsin deficiency: a longitudinal lung function study.
    de Hamel FA; Carrell RW
    N Z Med J; 1981 Dec; 94(697):407-10. PubMed ID: 6977750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.